原发性和获得性免疫缺陷研究杂志

Gene Therapy in Primary Immunodeficiencies

Ines Rosinha, Laura Costa, Mara Pinto, Natalia Barbosa and Patricia Rosinha

Gene Therapy in Primary Immunodeficiencies

Primary immunodeficiencies (PIDs) result from inherited mutations in genes involved in the production, function or survival of specific elements of the immune system (T, B, NK lymphocytes, neutrophils, antigen-presenting cells). Knowing that these elements derive from pluripotent hematopoietic stem cells, it has been tried to use allogeneic hematopoietic stem cell transplantation (HSCT) as an alternative for patients with a PID, which has proven to be an effective  therapeutic approach leading to immune restoration.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证